Literature DB >> 29170090

Mucolipidosis type III gamma: Three novel mutation and genotype-phenotype study in eleven patients.

Beyhan Tüysüz1, Özgür Kasapçopur2, Dilek Uludağ Alkaya3, Sezgin Şahin2, Betül Sözeri4, Gözde Yeşil5.   

Abstract

Mucolipidosis type III gamma (MLIII gamma) is a lysosomal storage disease characterized by joint stiffness, mild coarse face and corneal clouding, which becomes recognizable usually in childhood. Biallelic mutations in the GNPTG gene, which encode the γ subunit of the N-acetylglucosamine-1-phosphotransferase enzyme, are the underlying cause of MLIII gamma. The aim of this study is to evaluate the longitudinal findings and genotype of eleven patients from eight families with MLIII gamma and to establish a genotype-phenotype correlation. The most frequently observed initial finding was stiffness of finger joints, which detected in patients between 18month-olds and five year-olds. However, in four patients presented here, initial finding was knee pain or waddling gait, which started between six-16years of age. All patients also had variable degrees of stiffness on large joints. The longest follow up period was 16years while the shortest was three years and six months. We observed that the patients who had an early onset disease and severe joint stiffness had also rapidly progressive joint involvement mostly localized in hands, shoulders, and hip. However; the patients with late onset and/or mild joint stiffness experienced slowly progressive symptoms. Most patients dropped in their growth curve in time and the ones who were severely affected reached the final height below the third centile. Seven disease-causing mutations, three of them novel, were detected in GNPTG gene. According to our clinical observations c.493_494insC and c.283_284insC mutations lead to a severe phenotype and c.196C>T, c.347_349del, c.652_655delTACT and c.445delG/c.367A>G mutations seemed to generate a milder phenotype.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GNPTG; Genotype; Mucolipidosis III gamma; Phenotype

Mesh:

Substances:

Year:  2017        PMID: 29170090     DOI: 10.1016/j.gene.2017.11.052

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Clinical Characterization of Mucolipidoses II and III: A Multicenter Study.

Authors:  Taciane Alegra; Fernanda Sperb-Ludwig; Nicole Ruas Guarany; Erlane M Ribeiro; Charles M Lourenço; Chong Ae Kim; Eugênia R Valadares; Marcial Francis Galera; Angelina X Acosta; Dafne Dain Gandelman Horovitz; Ida Vanessa Doederlein Schwartz
Journal:  J Pediatr Genet       Date:  2019-09-24

2.  Clinical, radiological and computational studies on two novel GNPTG variants causing mucolipidosis III gamma phenotypes with varying severity.

Authors:  Mustafa Doğan; Recep Eröz; Kerem Terali; Alper Gezdirici; Semih Bolu
Journal:  Mol Biol Rep       Date:  2021-01-28       Impact factor: 2.316

3.  Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.

Authors:  Giorgia Di Lorenzo; Renata Voltolini Velho; Dominic Winter; Melanie Thelen; Shiva Ahmadi; Michaela Schweizer; Raffaella De Pace; Kerstin Cornils; Timur Alexander Yorgan; Saskia Grüb; Irm Hermans-Borgmeyer; Thorsten Schinke; Sven Müller-Loennies; Thomas Braulke; Sandra Pohl
Journal:  Mol Cell Proteomics       Date:  2018-05-17       Impact factor: 5.911

4.  Mucolipidosis type III, a series of adult patients.

Authors:  Esmee Oussoren; David van Eerd; Elaine Murphy; Robin Lachmann; Jan C van der Meijden; Lies H Hoefsloot; Rob Verdijk; George J G Ruijter; Mario Maas; Carla E M Hollak; Janneke G Langendonk; Ans T van der Ploeg; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2018-04-27       Impact factor: 4.982

5.  Niemann-Pick type A disease with new mutation: a case report.

Authors:  Fatemeh Aghamahdi; Matineh Nirouei; Shahram Savad
Journal:  J Med Case Rep       Date:  2022-07-27

6.  Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma.

Authors:  Lena Marie Westermann; Lutz Fleischhauer; Jonas Vogel; Zsuzsa Jenei-Lanzl; Nataniel Floriano Ludwig; Lynn Schau; Fabio Morellini; Anke Baranowsky; Timur A Yorgan; Giorgia Di Lorenzo; Michaela Schweizer; Bruna de Souza Pinheiro; Nicole Ruas Guarany; Fernanda Sperb-Ludwig; Fernanda Visioli; Thiago Oliveira Silva; Jamie Soul; Gretl Hendrickx; J Simon Wiegert; Ida V D Schwartz; Hauke Clausen-Schaumann; Frank Zaucke; Thorsten Schinke; Sandra Pohl; Tatyana Danyukova
Journal:  Dis Model Mech       Date:  2020-11-18       Impact factor: 5.758

Review 7.  Mucolipidoses Overview: Past, Present, and Future.

Authors:  Shaukat A Khan; Saori C Tomatsu
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

8.  Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III.

Authors:  Giorgia Di Lorenzo; Lena M Westermann; Timur A Yorgan; Julian Stürznickel; Nataniel F Ludwig; Luise S Ammer; Anke Baranowsky; Shiva Ahmadi; Elham Pourbarkhordariesfandabadi; Sandra R Breyer; Tim N Board; Anne Foster; Jean Mercer; Karen Tylee; Renata Voltolini Velho; Michaela Schweizer; Thomas Renné; Thomas Braulke; Dévora N Randon; Fernanda Sperb-Ludwig; Louise Lapagesse de Camargo Pinto; Carolina Araujo Moreno; Denise P Cavalcanti; Michael Amling; Kerstin Kutsche; Dominic Winter; Nicole M Muschol; Ida V D Schwartz; Tim Rolvien; Tatyana Danyukova; Thorsten Schinke; Sandra Pohl
Journal:  Genet Med       Date:  2021-08-02       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.